News Category
Helus Pharma has appointed Michael Halstead as CEO, bringing extensive biopharmaceutical experience to lead the company through pivotal Phase 3 trials...
Luke Van Der Veer's Website Rental Coaching program, which teaches local SEO and the 'Rank and Rent' model, has expanded to 14 countries with 467 stud...
Ireland has banned the use of electroconvulsive therapy (ECT) on individuals under 18, a move praised by human rights advocates who call for extending...
Helus Pharma completed enrollment in its pivotal Phase 3 APPROACH trial for HLP003, a deuterated psilocin analogue for major depressive disorder, with...
Helus Pharma announced fiscal 2026 financial results and provided updates on its clinical pipeline, with its lead candidate HLP003 for major depressiv...
Helus Pharma raised $50 million through a public offering to fund Phase 3 and Phase 2 trials for treatments of major depressive disorder and generaliz...
Helus Pharma has priced a $50 million public offering to fund Phase 3 development of HLP003 for major depressive disorder and other pipeline programs,...
Helus Pharma announced its Phase 3 APPROACH trial for HLP003 has surpassed 86% enrollment, keeping the study on track for topline data in Q4 2026, whi...
Helus Pharma announced that its Chief Medical Officer will participate in a fireside chat at the H.C. Wainwright Neuro Perspectives Conference, highli...
Craig Munro Wilson's 'Baptize America' examines the 1820 Campbell-Walker debate as a pivotal moment in American religious identity, arguing its theolo...
Helus Pharma issued a correction to its partnership announcement with TARA Mind, removing references to Veterans Exploring Treatment Solutions while r...
Helus Pharma added Dr. Robert Langer and Dr. Stephen Brannan to its Scientific Advisory Board, enhancing expertise in drug delivery and CNS developmen...
Helus Pharma announced the immediate departure of CEO Michael Cola and the appointment of co-founder Eric So as interim CEO, signaling continuity as t...
Helus Pharma has appointed Dr. Ken Kramer, a veteran with over 20 years of neuroscience medical affairs leadership, as Senior Vice President of Medica...
Europe's first data center powered by a microgrid has launched in Dublin, Ireland, offering a self-sufficient energy solution to meet the growing digi...
Helus Pharma announced positive Phase 2 results for HLP004 as an adjunctive treatment for generalized anxiety disorder, showing significant symptom re...
Helus Pharma's appointment of Dr. Freda Lewis-Hall, a veteran biopharmaceutical leader with over 40 years of experience, strengthens its governance as...
Helus Pharma announced that its Phase 2a trial of SPL026 for major depressive disorder showed significant symptom reduction and was published in Natur...
Helus Pharma's Q3 2025 financial results highlight progress in its Phase 3 major depressive disorder and Phase 2 generalized anxiety disorder programs...
Helus Pharma announced Michael Cola as new CEO, effective immediately, as the company advances toward Phase 2 data for HLP004 and Phase 3 topline data...
Fully Promoted closed its 25th year with systemwide sales growth, 57 new franchise agreements, 34 new locations, and three new master franchise partne...
Exit Factor, a franchise in business value enhancement and exit planning, plans to expand into New Zealand, Canada, Ireland, the Netherlands, and Aust...
YouTube is testing a new video-sharing and chat feature in Ireland and Poland, allowing users to share and discuss videos without leaving the app, whi...
Hydromer's partnership with Avem Market Solutions aims to provide European and UK medical device makers with easier access to high-performance coating...
Cybin Inc. will host a conference call on November 13, 2025, to report its second-quarter financial results and provide a business update, highlightin...
Cybin Inc. announced a $175 million registered direct offering with warrants, attracting prominent investors to fund late-stage clinical trials for it...
Padel 100 launches a €5 million EIIS raise to install 300 padel courts nationwide by December 2027, positioning Ireland as a fast-emerging padel marke...
